Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD

Summary

To evaluate the safety of 3 regimens of short-term, low-dose systemic IMT as rejection prophylaxis prior to and/or following transplant of MA09-hRPE cells.

Timeline

Start

2015-08-24

Primary completion

2017-05-05

Completion

2017-05-05

Outcome

Outcome not reported

Stopped: “Changes to the study design and the cell line”

Drugs

Indications